Meningiomas are the most common primary brain tumor. They arise from the membranes surrounding the brain and spinal cord and ...

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns ...

The U.S. Food and Drug Administration (FDA) has approved a significant update to the prescribing information for Depo-Provera ...

New research suggests that use of depot medroxyprogesterone acetate may be associated with an increased risk for fracture in women, particularly in those with longer treatment duration and multiple ...

September 16, 2009 (Denver, Colorado) — Long-term use of the contraceptive depot medroxyprogesterone acetate (DMPA) has been associated with impaired bone-mineral acquisition in adolescents and ...

Nearly half of women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, will experience high bone mineral density (BMD) loss in the hip or lower spine within two ...

In a large, prospective, longitudinal study, Clark et al. investigated the changes in weight and fat gain of women receiving the hormonal contraceptive, depot medroxyprogesterone acetate (DMPA), for ...

Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associated with an increased risk of HIV acquisition. This study compares effects of ...